Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders

Movement Disorders

Volumn 12, Issue 6, 1997, Pages 903-909

  Federico, Francesco ^a   Simone, Isabella L ^a   Lucivero, Vincenzo ^a   Iliceto, Giovanni ^a   De Mari, Michele ^a   Giannini, Paolo ^a   Mezzapesa, Domenico M ^a   Tarantino, Alfredo ^a   Lamberti, Paolo ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Magnetic resonance spectroscopy; Multiple system atrophy; Parkinson's disease; Progressive supranuclear palsy

Indexed keywords

CHOLINE; CREATINE PHOSPHATE; N ACETYLASPARTIC ACID;

ADULT; AGED; ARTICLE; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOBUS PALLIDUS; HUMAN; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTON NUCLEAR MAGNETIC RESONANCE; PUTAMEN; SHY DRAGER SYNDROME;

AGED; ANTIPARKINSON AGENTS; ASPARTIC ACID; ATROPHY; CEREBRAL CORTEX; CHOLINE; CORPUS STRIATUM; CREATININE; FEMALE; GLOBUS PALLIDUS; HUMANS; LEVODOPA; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; PARKINSON DISEASE; PARKINSON DISEASE, SECONDARY; PHOSPHOCREATINE; PROTONS; PUTAMEN; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 0030713320     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870120611     Document Type: Article

References (11)

1. Colosimo C, Albanese A, Hughes AJ, de Bruin VM, Lees AJ. Some specific clinical features differentiate multiple system atro-phy (striatonigral variety) from Parkinson's disease. Arch Neurol 1995;52:294-298.
2. Quinn N. Parkinsonism: recognition and differential diagnosis. BMJ 1995;310:447-452.
3. Wenning GK, Ben-Shlomo Y, Magalhaes M, Daniel SE, Quinn NP. Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry 1995;58:160-166.
4. Litvan I, Agid Y, Jankovic J, et al. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology 1996;46:922-930.
5. Forno L.S. Pathology of Parkinson's disease. In: Marsden CD, Fahn S, eds. Movement disorders. London: Butterworths, 1982: 25-40.
6. Jellinger KA. Neurodegenerative disorders with extrapyramidal features: a neuropathological overview. J Neural Trans 1995;46 (suppl):33-57.
7. Golbe LI, Davis PH. Progressive supranuclear palsy. In: Jankovic J, Tolosa E, eds. Parkinson's Disease and Movement Disorders. Baltimore: Urban and Schwarzenberg, 1988:121-130.
8. Savoiardo M, Girotti F, Strada L, Ciceri E. Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders. J Neural Transm 1994;42(suppl):93-110.
9. Brooks DJ. PET studies in progressive supranuclear palsy. J Neural Transm 1994;42(suppl):l19-134.
10. 18F-dopa PET data. J Neurol Neurosurg Psychiatry 1994;57:228-284.
11. 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 1991;4: 47-52.